Show simple item record

dc.contributor.authorWarren, Robin
dc.contributor.authorCarlisle, Karen
dc.contributor.authorMihala, Gabor
dc.contributor.authorScuffham, Paul A
dc.date.accessioned2018-05-09T01:53:13Z
dc.date.available2018-05-09T01:53:13Z
dc.date.issued2018
dc.identifier.issn1357-633X
dc.identifier.doi10.1177/1357633X17723943
dc.identifier.urihttp://hdl.handle.net/10072/374752
dc.description.abstractIntroduction: This study examined the effect of a telehealth intervention on the control of type 2 diabetes and subsequent potential cost-savings to the health system. Methods: This prospective randomised controlled trial randomised adults with type 2 diabetes to the intervention (diabetes program) or control (usual care) arm. Key eligibility criteria included an HbA1c level of at least 58 mmol/mol (7.5%) without severe or unstable comorbidities. All participants continued their usual healthcare, but participants in the intervention arm received additional diabetes care from a diabetes care coordinator via a home monitor that captured clinical measures. Data collected included biomedical, quality of life measures and healthcare (GP, outpatient and inpatient) costs. The primary outcome was HbA1c collected at baseline and 6 months. Analysis was conducted on a complete case intention-to-treat basis. The healthcare system perspective was taken to calculate the incremental cost per percentage-point reduction in HbA1c. Results: Results from 63 participants from each study arm were analysed. HbA1c in the intervention group decreased from a median 68 mmol/mol (8.4%) to 58 mmol/mol (7.5%), and remained unchanged in the control group at median 65 mmol/mol (8.1%) at the 6-month endpoint. The intervention effect on HbA1c change was statistically significant (p = .004). Total healthcare costs in the intervention group, including the intervention costs, were lower (mean $3781 vs. $4662; p < .001) compared with usual care. Discussion: There was a clinically meaningful and statistically significant benefit from the telehealth intervention at a lower cost; thus, telehealth was cost-saving and produced greater health benefits compared with usual care.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherSage Publications
dc.relation.ispartofpagefrom1
dc.relation.ispartofpageto10
dc.relation.ispartofjournalJournal of Telemedicine and Telecare
dc.subject.fieldofresearchPublic Health and Health Services not elsewhere classified
dc.subject.fieldofresearchBiomedical Engineering
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchInformation Systems
dc.subject.fieldofresearchcode111799
dc.subject.fieldofresearchcode0903
dc.subject.fieldofresearchcode1117
dc.subject.fieldofresearchcode0806
dc.titleEffects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.description.notepublicThis publication has been entered into Griffith Research Online as an Advanced Online Version.
gro.hasfulltextNo Full Text
gro.griffith.authorScuffham, Paul A.
gro.griffith.authorMihala, Gabor


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record